Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,369,172
+$2,600,209 QoQ
Shares Held
92,749
+11.5% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 341 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,716 across 210 Biotechnology names. PTGX ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,369,172 | 92,749 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,768,963 | 83,197 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,261,798 | 37,346 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,923,649 | 44,011 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,483,391 | 44,932 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,814,852 | 37,528 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $948,324 | 24,568 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,578,510 | 35,078 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,447,087 | 41,763 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,208,058 | 41,758 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $853,660 | 37,229 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $670,802 | 40,216 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,989,081 | 72,016 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $819,697 | 35,639 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $392,159 | 35,945 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $308,217 | 36,562 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $957,149 | 121,005 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,095,402 | 130,718 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,525,104 | 132,313 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $818,221 | 46,175 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,781,245 | 106,534 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $2,250,192 | 86,880 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||